96 related articles for article (PubMed ID: 18558512)
1. Angiogenic evaluation of ginsenoside Rg 1 from Panax ginseng in fluorescent transgenic mice.
Lin KM; Hsu CH; Rajasekaran S
Vascul Pharmacol; 2008 Jul; 49(1):37-43. PubMed ID: 18558512
[TBL] [Abstract][Full Text] [Related]
2. Stability of angiogenic agents, ginsenoside Rg1 and Re, isolated from Panax ginseng: in vitro and in vivo studies.
Yu LC; Chen SC; Chang WC; Huang YC; Lin KM; Lai PH; Sung HW
Int J Pharm; 2007 Jan; 328(2):168-76. PubMed ID: 16962729
[TBL] [Abstract][Full Text] [Related]
3. A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration.
Huang YC; Chen CT; Chen SC; Lai PH; Liang HC; Chang Y; Yu LC; Sung HW
Pharm Res; 2005 Apr; 22(4):636-46. PubMed ID: 15846472
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro.
Yue PY; Wong DY; Ha WY; Fung MC; Mak NK; Yeung HW; Leung HW; Chan K; Liu L; Fan TP; Wong RN
Angiogenesis; 2005; 8(3):205-16. PubMed ID: 16328162
[TBL] [Abstract][Full Text] [Related]
5. Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration.
Liang HC; Chen CT; Chang Y; Huang YC; Chen SC; Sung HW
Tissue Eng; 2005; 11(5-6):835-46. PubMed ID: 15998223
[TBL] [Abstract][Full Text] [Related]
6. In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity.
Kragh M; Hjarnaa PJ; Bramm E; Kristjansen PE; Rygaard J; Binderup L
Int J Oncol; 2003 Feb; 22(2):305-11. PubMed ID: 12527927
[TBL] [Abstract][Full Text] [Related]
7. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
Yue PY; Wong DY; Wu PK; Leung PY; Mak NK; Yeung HW; Liu L; Cai Z; Jiang ZH; Fan TP; Wong RN
Biochem Pharmacol; 2006 Aug; 72(4):437-45. PubMed ID: 16793023
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.
Wang W; Zhao Y; Rayburn ER; Hill DL; Wang H; Zhang R
Cancer Chemother Pharmacol; 2007 Apr; 59(5):589-601. PubMed ID: 16924497
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis model for ultrasound contrast research: exploratory study.
Lucidarme O; Nguyen T; Kono Y; Corbeil J; Choi SH; Varner J; Mattrey RF
Acad Radiol; 2004 Jan; 11(1):4-12. PubMed ID: 14746396
[TBL] [Abstract][Full Text] [Related]
10. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
[TBL] [Abstract][Full Text] [Related]
11. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
[TBL] [Abstract][Full Text] [Related]
12. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
13. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor.
Kimura Y; Ozeki M; Inamoto T; Tabata Y
Tissue Eng; 2002 Aug; 8(4):603-13. PubMed ID: 12202000
[TBL] [Abstract][Full Text] [Related]
14. Multiple effects of bevacizumab in angiogenesis: implications for its use in age-related macular degeneration.
Carneiro A; Falcão M; Azevedo I; Falcão Reis F; Soares R
Acta Ophthalmol; 2009 Aug; 87(5):517-23. PubMed ID: 18717653
[TBL] [Abstract][Full Text] [Related]
15. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
Skovseth DK; Küchler AM; Haraldsen G
Methods Mol Biol; 2007; 360():253-68. PubMed ID: 17172733
[TBL] [Abstract][Full Text] [Related]
16. Immunopotentiation and antitumor effects of a ginsenoside Rg₃-fortified red ginseng preparation in mice bearing H460 lung cancer cells.
Park D; Bae DK; Jeon JH; Lee J; Oh N; Yang G; Yang YH; Kim TK; Song J; Lee SH; Song BS; Jeon TH; Kang SJ; Joo SS; Kim SU; Kim YB
Environ Toxicol Pharmacol; 2011 May; 31(3):397-405. PubMed ID: 21787710
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.
Woodman SE; Ashton AW; Schubert W; Lee H; Williams TM; Medina FA; Wyckoff JB; Combs TP; Lisanti MP
Am J Pathol; 2003 Jun; 162(6):2059-68. PubMed ID: 12759260
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
19. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
20. Intestinal smooth muscle cell maintenance by basic fibroblast growth factor.
Lee M; Wu BM; Stelzner M; Reichardt HM; Dunn JC
Tissue Eng Part A; 2008 Aug; 14(8):1395-402. PubMed ID: 18680389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
